The COVID-NMA initiative
A living mapping and living systematic review of Covid-19 trials
COVID-NMA is an international research initiative supported by the WHO and Cochrane.
We provide a living mapping of COVID-19 trials. We are also conducting living evidence synthesis on preventive interventions, treatments and vaccines for COVID-19 to assist decision makers.
See the description of our model here and our living review protocol here.
LIVING MAPPING OF TRIALS
(i.e., trials registered on the WHO platform)Updated weekly
4478
Randomized Trials
1259 RCTs recruiting
LIVING SYNTHESIS OF PUBLISHED STUDIES
(include both articles and preprints)Updated daily
810
Studies (RCTs or Observational studies) with complete data extraction and results
included in our evidence synthesis
meta-COVID
Of note, as of March 1, 2022, the COVID-NMA revised its protocol and reduced its scope.
Only comparisons evaluating antivirals and immunomodulators will continue to be updated every two weeks.
Perform your own analysis using COVID-NMA data, create and download your forest plots by clicking below:
Summary of Main Results
Summary of the evidence for treatment of hospitalized COVID-19 patients identified up to September 5, 2022 is available below.
It will be updated monthly.
For earlier editions of the summary of main results, click here
BI-WEEKLY UPDATE
September 5 to September 16, 2022. see the update here.
Newsletter
To receive updates on our project, please subscribe below.
Excluded Studies
Download CSV file (last update: 2022-09-20).
Retracted Studies
Download CSV file (last update: 2022-09-15).